Buradasınız

Anasayfa » Content

Obstrüktif Uyku Apne Sendromu Progresyonuna Etki Eden Faktörlerin İncelenmesi

Evaluation of the Effecting Factors on the Progression of Obstructive Apnea Syndrome

Journal Name:

  • Uludağ Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2010

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
The aim of the study is to investigate the impacts of various etiological factors and/or co-morbiities on increasing clinical severity profiles of obstructive sleep apnea syndrome (OSAS). 172 subjects who were admitted with daytime sleepiness and were informed to have at least one of the apnea symptoms and then were undergone to the diagnostic polysomnography procedure. Patients were divided into four subgroups based on their apnea-hypoapnea indices. Simple snoring group was accepted as the control group for comparisons. Simple snoring and mild, moderate and severe OSAS were demonstrated in 50 (29.1%), 38 (22.1%), 43 (25%) and 41 (23.8%) of patients based on AHI values. For severe OSAS male sex and body mass index and for moderate OSAS hypertension and hyperlipidemia were statistically higher based on correlative evaluations (p<0.05). The deteriorating effects of BMI and diabetes on functions of nerves and muscles could be considered to be responsible of the increasing severity of OSAS.
Bookmark/Search this post with
Abstract (Original Language): 
Obstrüktif uyku apne sendromu (OUAS) üzerine etkili olabilecek etyolojik ve/veya çeşitli komorbid durumların hafiften ağıra doğru giden klinik spektrum üzerindeki yerlerini araştırmaktır. Çalışmaya horlama, gündüz aşırı uyku hali ve yakınları tarafından bildirilen apne semptomlarından bir ya da daha fazlası ile başvuran ve bir gece uyku laboratuvarında yatırılarak tanısal polisomnografi (PSG) yapılan 172 olgu dâhil edildi. Apne hipopne indeksine (AHİ) göre hastalar 4 gruba ayrıldı. Basit horlama hastaları kontrol grubu olarak kabul edildi. Hastalar AHİ değerlerine göre basit horlama 50 (%29.1) , hafif OUAS 38 (%22.1), orta OUAS 43 (%25) ve ağır OUAS 41 (%23.8) olarak gruplandı- rıldı. Erkek cinsiyet ve vücut kitle indeksi ağır şiddette OUAS grubunda, hipertansiyon ve hiperlipidemi orta şiddette OUAS grubunda istatistiksel açıdan anlamlı olarak fazla saptandı (P <0.05). OUAS şiddetinin ağırlaşmasına vücut kitle indeksi ve diyabetin sinir ve kaslar üzerinde yarattığı fonksiyon bozukluğunun daha etkili olabileceği düşünülmektedir
FULL TEXT (PDF): 
PDF icon arastirmax-obstruktif-uyku-apne-sendromu-progresyonuna-etki-eden-faktorlerin-incelenmesi.pdf
  • 3
81-84
  • Turkish

REFERENCES

References: 

1. American Academy of Sleep Medicine (AASM). International
classification of sleep disorders, 2nd ed: Diagnostic and coding
manual, Westchester, IL 2005.
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S.
Theoccurrence of sleep-disordered breathing among middleaged adults. N Engl J Med 1993;328:1230–5
3. Strauss RS, Browner WS. Risk for Obstructive Sleep Apnea.
Ann Intern Med 2000;132:758-9
4. National comission on sleep disorders research: Wake up
America: Anational sleep alert. (Volume 1). Bethesda MD 1995.
5. Gould GA, Whyte KF, Rhind GB, et al. The sleep hypopnea
syndrome. Am Rev Respir Dis 1988; 137: 895-8
6. Köktürk O. Obstrüktif Uyku Apne Sendromu Epidemiyolojisi.
Tüberküloz ve Toraks Dergisi 1998;46:193-201
7. National Institutes of Health. Clinical Guidlines on the
identfication, evaluation, and treatment of overweight and
obesity in adults: The evidence report. Obes Res 1998;6:51-209.
8. Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian
A.Cyclical variation of the heart rate in sleep apnoea syndrome.
Mechanisms and usefulness of 24 h electrocardiography as a
screening technique. Lancet. 1984;1(8369):126-31.) (Young T,
Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea
in adults. JAMA. 2004;291:2013-6.
9. Philips BG, Somers VK. Sleep disordered breathing and risk
factors for cardiovascular disease. Curr Opin Pulm Med.
2002;8(6):516-20.
10. Kario K. Obstructive sleep apnea syndrome and hypertension:
ambulatory blood pressure. Hypertens Res. 2009 Jun;32:428-32.
11. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R,
Niroumand M, Leung RS, Bradley TD. High prevalence of
unrecognized sleep apnoea in drug-resistant hypertension.
JHypertens. 2001;19:2271-7.
12. Sharabi Y, Dagan Y, Grossman E. Sleep apnea as a risk factor
for hypertension. Curr Opin Nephrol Hypertens. 2004;13:359-
64.25.
13. Misawa S, Kuwabara S, Kanai K, Tamura N, Nakata M, Sawai
S. Aldose reductase inhibition alters nodal Na+ currents and
nerve conduction in human diabetics. Neurology.
2006;66:1545-4
14. Feldman EL, Russel JW, Sullivan KA, Golovoy D. New
insights into the pathogenesis of diabetic neuropathy. Curr Opin
Neurol 1999;12(5):553–63.
15. Larsson H, Daugaard JR, Kiens B, Richter EA, Ahren B.
Muscle fiber characteristics in postmenopausal women with
normal or impaired glucose tolerance. Diabetes Care
1999;22:1330-8.
16. Stalberg E. Macroelectromyography in reinnervation. Muscle
Nerve 1982;5: 135–8.
17. Papanas N, Steiropoulos P, Nena E, Tzouvelekis A, Skarlatos
A, Konsta M, Vasdekis V, Maltezos E, Bouros D. Predictors of
obstructive sleep apnea in males with metabolic syndrome.
Vasc Health Risk Manag. 2010 May 6;6:281-6.
18. Ficker JH, Dertinger SH, Siegfried W et al. Obstructive sleep
apnoea and diabetes mellitus: the role of cardiovascular
autonomic neuropathy. Eur Resp J 1998; 11:14-19.

Thank you for copying data from http://www.arastirmax.com